Trimodal Prehabilitation in Colorectal Cancer Patients: a Feasibility Pilot

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement, Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical pilot is to determine the feasibility of implementing trimodal prehabilitation within the current perioperative infrastructure in patients having major colorectal surgery for resection of a cancer (CRC). Trimodal prehabilitation includes exercise, nutrition and mindfulness coaching and support which has been shown to improve physical status, mental preparation and to reduce loss of lean body mass in CRC patients. The primary questions this study aims to answer are: Is delivery of trimodal prehabilitation feasible within our current perioperative infrastructure and does prehabilitation impact outcomes in these patients? Researchers will compare this newly recruited prehabilitation cohort to a historical cohort of patients who did not receive prehabilitation in terms of mortality, length of stay, complications, readmissions, emergency department visits and non-home discharge.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• age 18 or older

• major colorectal surgery (colectomy, low anterior resection or abdominoperineal resection)

Locations
Other Locations
Canada
Kingston Health Sciences Centre
RECRUITING
Kingston
Contact Information
Primary
Jordan Leitch, MD
Jordan.Leitch@Kingstonhsc.ca
6134494223
Time Frame
Start Date: 2023-07-24
Estimated Completion Date: 2025-06-30
Participants
Target number of participants: 50
Treatments
Other: Progress Check
This arm will include pre- and post-prehabilitation questionnaires as well as twice weekly progress checks by the research assistant to check on participant progress, answer questions and provide accountability and motivation.
Other: No Progress Check
This arm will include only pre- and post-prehabilitation questionnaires.
Related Therapeutic Areas
Sponsors
Leads: Jordan Leitch

This content was sourced from clinicaltrials.gov